{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:09:44Z","timestamp":1790946584114,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Canadian Scleroderma Research Group"},{"name":"CSRG"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["#FRN 83518"],"award-info":[{"award-number":["#FRN 83518"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scleroderma Society of Canada"},{"name":"Scleroderma Society of Ontario"},{"name":"Scleroderma Society of Saskatchewan"},{"name":"Scl\u00e9rodermie Qu\u00e9bec"},{"name":"Cure Scleroderma Foundation"},{"name":"INOVA Diagnostics Inc"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fonds de la recherche du Qu\u00e9bec \u2013 Sant\u00e9"},{"DOI":"10.13039\/501100000156","name":"FRQS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Scleroderma Interest Group (ASIG)"},{"name":"Scleroderma Australia"},{"name":"Scleroderma Victoria"},{"DOI":"10.13039\/501100000940","name":"Arthritis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000940","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Actelion Australia"},{"DOI":"10.13039\/501100011578","name":"MOVE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011578","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Australian Rheumatology Association"},{"name":"The Scleroderma Clinical Trials Consortium"},{"name":"St Vincent\u2019s Hospital Research Endowment Fund"},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CSL Biotherapies"},{"DOI":"10.13039\/501100001203","name":"GlaxoSmithKline Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"name":"H\u00f4pital Maisonneuve Rosemont Department of Medicine Foundation"},{"name":"Fonds de la recherche du Qu\u00e9bec \u2013 Sant\u00e9"},{"DOI":"10.13039\/501100000156","name":"FRQS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health and Medical Research Council of Australia","award":["APP 1126370"],"award-info":[{"award-number":["APP 1126370"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine the incidence, predictors and outcomes associated with severe gastrointestinal (GI) disease in a large inception SSc cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>SSc subjects with &lt;2 years of disease duration were identified from two multicentre cohorts. Severe GI disease was defined as: malabsorption, hyperalimentation, pseudo-obstruction and\/or \u2a7e10% weight loss in association with the use of antibiotics for bacterial overgrowth or oesophageal stricture. Kaplan\u2013Meier, multivariate logistic regression and Cox proportional hazard analyses were performed to determine the cumulative incidence rate, independent clinical correlates and mortality rate associated with severe GI disease. A longitudinal mixed model was used to assess the impact of severe GI disease on the Short Form Health Survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this inception SSc cohort, the probability of developing severe GI disease was estimated at 9.1% at 2 years and 16.0% at 4 years. In multivariate analysis, severe GI disease was associated with inflammatory myositis (odds ratio 4.68, 95% CI 1.65, 13.24), telangiectasias (odds ratio 2.45, 95% CI 1.19, 5.04) and modified Rodnan skin score (odds ratio 1.03, 95% CI 1.01, 1.07). Severe GI disease was associated with a &gt;2-fold increase in the risk of death (hazard ratio 2.27, 95% CI 1.27, 4.09) and worse health-related quality of life [Short Form Health Survey physical (\u03b2 = \u22122.37, P = 0.02) and mental (\u03b2 = \u22122.86, P = 0.01) component summary scores].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Severe GI disease is common in early SSc and is associated with significant morbidity and increased mortality. More research is needed to understand, prevent and mitigate severe GI disease in SSc.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/key350","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T15:08:58Z","timestamp":1540048138000},"page":"636-644","source":"Crossref","is-referenced-by-count":59,"title":["Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality"],"prefix":"10.1093","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3683-8713","authenticated-orcid":false,"given":"Nicolas","family":"Richard","sequence":"first","affiliation":[{"name":"Division of Rheumatology, H\u00f4pital Maisonneuve-Rosemont, Montreal, Quebec, Canada"},{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hudson","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"Division of Rheumatology, Jewish General Hospital, Montreal, Quebec, Canada"},{"name":"Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mianbo","family":"Wang","sequence":"additional","affiliation":[{"name":"Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Gyger","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"Division of Rheumatology, Jewish General Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Proudman","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia"},{"name":"Discipline of Medicine, University of Adelaide, Adelaide, South Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, St Vincent\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, St Vincent\u2019s Hospital, Melbourne, Victoria, Australia"},{"name":"Department of Medicine, University of Melbourne at St Vincent\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Canadian Scleroderma Research Group (CSRG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gyger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Larch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Khalidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Masetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T S","family":"Rodriguez-Reyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P R","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Australian Scleroderma Interest Group (ASIG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Croyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"de Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Ferdowsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Morrisroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Ngian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rischmueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Roddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sahhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Schrieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sturgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Tymms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Youseff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Zochling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Baron","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"Division of Rheumatology, Jewish General Hospital, Montreal, Quebec, Canada"},{"name":"Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"2019081609502710400_key350-B1","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/art.1780370902","article-title":"Gastrointestinal motility disorders in scleroderma","volume":"37","author":"Sjogren","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2019081609502710400_key350-B2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"2019081609502710400_key350-B3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2019081609502710400_key350-B4","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2019081609502710400_key350-B5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10620-007-0018-8","article-title":"Gastrointestinal manifestations of systemic sclerosis","volume":"53","author":"Domsic","year":"2008","journal-title":"Dig Dis Sci"},{"key":"2019081609502710400_key350-B6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.20452\/pamw.907","article-title":"Gastrointestinal involvement in patients with systemic sclerosis","volume":"120","author":"Wielosz","year":"2010","journal-title":"Pol Arch Med Wewn"},{"key":"2019081609502710400_key350-B7","doi-asserted-by":"crossref","first-page":"iii36","DOI":"10.1093\/rheumatology\/ken485","article-title":"Gastrointestinal complications: the most frequent internal complications of systemic sclerosis","volume":"48","author":"Forbes","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2019081609502710400_key350-B8","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2019081609502710400_key350-B9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/acr.22451","article-title":"2013 American College of Rheumatology\/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group","volume":"67","author":"Alhajeri","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2019081609502710400_key350-B10","first-page":"581","article-title":"Masi AT, Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2019081609502710400_key350-B11","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"2019081609502710400_key350-B12","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2019081609502710400_key350-B13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"2019081609502710400_key350-B14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s11136-010-9658-9","article-title":"New Australian population scoring coefficients for the old version of the SF-36 and SF-12 health status questionnaires","volume":"19","author":"Tucker","year":"2010","journal-title":"Qual Life Res"},{"key":"2019081609502710400_key350-B15","first-page":"1117","article-title":"Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases","volume":"33","author":"Johnson","year":"2006","journal-title":"J Rheumatol"},{"key":"2019081609502710400_key350-B16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0248-8663(03)00268-6","article-title":"[Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis]","volume":"25","author":"Georges","year":"2004","journal-title":"Rev Med Interne"},{"key":"2019081609502710400_key350-B17","first-page":"832","article-title":"Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial","volume":"32","author":"Khanna","year":"2005","journal-title":"J Rheumatol"},{"key":"2019081609502710400_key350-B18","first-page":"84","article-title":"The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis","volume":"25","author":"Furst","year":"1998","journal-title":"J Rheumatol"},{"key":"2019081609502710400_key350-B19","first-page":"1892","article-title":"Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies","volume":"20","author":"Clements","year":"1993","journal-title":"J Rheumatol"},{"key":"2019081609502710400_key350-B20","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.3899\/jrheum.140236","article-title":"Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects","volume":"41","author":"Diab","year":"2014","journal-title":"J Rheumatol"},{"key":"2019081609502710400_key350-B21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/acr.21583","article-title":"Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis","volume":"64","author":"Steele","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2019081609502710400_key350-B22","first-page":"458","article-title":"Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization","volume":"35","author":"Hsu","year":"2008","journal-title":"J Rheumatol"},{"key":"2019081609502710400_key350-B23","author":"Winter","year":"2013"},{"key":"2019081609502710400_key350-B24","author":"Bates","year":"2014"},{"key":"2019081609502710400_key350-B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v082.i13","article-title":"lmerTest package: tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J Stat Softw"},{"key":"2019081609502710400_key350-B26","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3899\/jrheum.121380","article-title":"The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review","volume":"40","author":"Muangchan","year":"2013","journal-title":"J Rheumatol"},{"key":"2019081609502710400_key350-B27","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s12026-017-8926-y","article-title":"Pathogenesis of systemic sclerosis-current concept and emerging treatments","volume":"65","author":"Furue","year":"2017","journal-title":"Immunol Res"},{"key":"2019081609502710400_key350-B28","doi-asserted-by":"crossref","first-page":"G1052","DOI":"10.1152\/ajpgi.00034.2016","article-title":"Role of muscarinic-3 receptor antibody in systemic sclerosis: correlation with disease duration and effects of IVIG","volume":"310","author":"Kumar","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2019081609502710400_key350-B29","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/apt.13963","article-title":"Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis","volume":"45","author":"Kumar","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2019081609502710400_key350-B30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0016-5085(89)90770-1","article-title":"Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis","volume":"96","author":"Greydanus","year":"1989","journal-title":"Gastroenterology"},{"key":"2019081609502710400_key350-B31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2013-203889","article-title":"Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS\/EUSTAR centre","volume":"74","author":"Lepri","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2019081609502710400_key350-B32","first-page":"2050","article-title":"Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement","volume":"34","author":"Nishimagi","year":"2007","journal-title":"J Rheumatol"},{"key":"2019081609502710400_key350-B33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3109\/03009742.2011.579575","article-title":"Faecal incontinence in patients with systemic sclerosis: is an impaired internal anal sphincter the only cause?","volume":"40","author":"Fynne","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"2019081609502710400_key350-B34","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/acr.22766","article-title":"Skin telangiectasia and the identification of a subset of systemic sclerosis patients with severe vascular disease","volume":"68","author":"Hurabielle","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2019081609502710400_key350-B35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3899\/jrheum.090697","article-title":"Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension","volume":"37","author":"Shah","year":"2010","journal-title":"J Rheumatol"},{"key":"2019081609502710400_key350-B36","doi-asserted-by":"crossref","first-page":"iii14","DOI":"10.1093\/rheumatology\/kep108","article-title":"Skin disease: a cardinal feature of systemic sclerosis","volume":"48","author":"Krieg","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"2019081609502710400_key350-B37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1586\/1744666X.2016.1115717","article-title":"Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course","volume":"12","author":"Becker","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"2019081609502710400_key350-B38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11926-011-0217-3","article-title":"Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management","volume":"14","author":"Gyger","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"2019081609502710400_key350-B39","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00002281-199611000-00012","article-title":"Gastrointestinal features of scleroderma","volume":"8","author":"Sjogren","year":"1996","journal-title":"Curr Opin Rheumatol"},{"key":"2019081609502710400_key350-B40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2017.09.002","article-title":"Gastrointestinal and hepatic disease in systemic sclerosis","volume":"44","author":"Frech","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"2019081609502710400_key350-B41","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.semarthrit.2015.04.009","article-title":"Thinking outside the box\u2014the associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect","volume":"45","author":"Srivastava","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2019081609502710400_key350-B42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004836-200102000-00006","article-title":"Autoantibody profile in progressive systemic sclerosis as markers for esophageal involvement","volume":"32","author":"Gonzalez","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"2019081609502710400_key350-B43","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3899\/jrheum.110826","article-title":"Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis","volume":"39","author":"Omair","year":"2012","journal-title":"J Rheumatol"},{"key":"2019081609502710400_key350-B44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semarthrit.2016.02.005","article-title":"Impaired quality of life in systemic sclerosis and patient perception of the disease: a large international survey","volume":"46","author":"Frantz","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2019081609502710400_key350-B45","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10067-012-1997-1","article-title":"Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools","volume":"31","author":"Strickland","year":"2012","journal-title":"Clin Rheumatol"},{"key":"2019081609502710400_key350-B46","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1177\/0962280216677879","article-title":"Analysis of an incomplete longitudinal composite variable using a marginalized random effects model and multiple imputation","volume":"27","author":"Gosho","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"2019081609502710400_key350-B47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12955-014-0192-2","article-title":"Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study","volume":"12","author":"Anota","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"2019081609502710400_key350-B48","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/rheumatology\/kes390","article-title":"Low prevalence of coeliac disease in patients with systemic sclerosis: a cross-sectional study of a registry cohort","volume":"52","author":"Forbess","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2019081609502710400_key350-B49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1590\/S0004-28032011000200014","article-title":"Celiac disease screening in patients with scleroderma","volume":"48","author":"Nisihara","year":"2011","journal-title":"Arg Gastroenterol"},{"key":"2019081609502710400_key350-B50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12891-015-0693-0","article-title":"Reduced incidence of Crohn\u2019s disease in systemic sclerosis: a nationwide population study","volume":"16","author":"Tseng","year":"2015","journal-title":"BMC Musculosket Disord"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/58\/4\/636\/28719938\/key350.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:56:29Z","timestamp":1775249789000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/58\/4\/636\/5230884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,12,4]]},"published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/key350","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4]]},"published":{"date-parts":[[2018,12,4]]}}}